The experience of inflammatory bowel disease patients with healthcare-Reference-Cited by-同舟云学术

The experience of inflammatory bowel disease patients with healthcare

Published:2019-04 Issue:14 Volume:98 Page:e15044
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Marín-Jiménez Ignacio,Casellas Francesc,Cortés Xavier,García-Sepulcre Mariana F.,Juliá Berta,Cea-Calvo Luis,Soto Nadia,Navarro-Correal Ester,Saldaña Roberto,de Toro Javier,Galindo María J.,Orozco-Beltrán Domingo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference34 articles.

1. A systematic review of evidence on the links between patient experience and clinical safety and effectiveness;Doyle;BMJ Open,2013

2. High-quality chronic care delivery improves experiences of chronically ill patients receiving care;Cramm;Int J Qual Health Care,2013

3. The importance of productive patient-professional interaction for the well-being of chronically ill patients;Cramm;Qual Life Res,2015

4. The role of patient care teams in chronic disease management;Wagner;BMJ,2000

5. Impairment of health-related quality of life in patients with inflammatory bowel disease: a Spanish multicenter study;Casellas;Inflamm Bowel Dis,2005

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Substantial cost savings of ultrasound-based management over magnetic resonance imaging-based management in an inflammatory bowel disease service;Scandinavian Journal of Gastroenterology;2024-03-19

2. Evaluación de la experiencia asistencial en pacientes con Enfermedad Renal Crónica Avanzada;Enfermería Nefrológica;2023-09-30

3. VALIDAÇÃO DO INSTRUMENTO DE EVALUACIÓN DE LA EXPERIENCIA DEL PACIENTE CRÓNICO PARA O PORTUGUÊS DO BRASIL;Texto & Contexto - Enfermagem;2023

4. VALIDATION OF INSTRUMENTO DE EVALUACIÓN DE LA EXPERIENCIA DEL PACIENTE CRÓNICO FOR BRAZILIAN PORTUGUESE;Texto & Contexto - Enfermagem;2023

5. Effectiveness on adherence to biological drugs and experience of a pharmaceutical intervention based on CMO model in patients with rheumatic disease (AdhER-2 study);Anales del Sistema Sanitario de Navarra;2022-08-16